Wondercel Therapeutics
Latest round
- Series A
Last raised
- Jul 2026
Total raised
- $35M
Investors
- 3
About Wondercel Therapeutics
, trading as Wondercel Therapeutics, is a cell and gene therapy developer dedicated to exploring solutions to the shortcomings of existing cell drugs and developing safer and more economical next-generation immune cell therapy technologies to unleash the unlimited potential of human immune cells in the treatment of tumors, organ transplantation, and autoimmune diseases. Wondercel Therapeutics specializes in the development of advanced cellular therapies aimed at addressing a variety of chronic health conditions. Their core product offerings include proprietary solutions that leverage stem cell technology, specifically designed to regenerate damaged tissues and enhance overall cellular function. These products target conditions such as degenerative diseases, wound healing, and age-related ailments, effectively providing patients with alternatives to traditional treatment methods. The company serves a diverse client base, including hospitals, specialized clinics, and healthcare providers primarily located in North America and Europe, where they have strategically positioned their therapies to meet the growing demand for innovative healthcare solutions. Wondercel Therapeutics generates revenue primarily through a combination of direct-to-consumer sales and partnerships with healthcare providers. The company has established a structured pricing model for its flagship therapeutic products, which may involve both one-time purchases and subscription services for ongoing treatment plans. Transactions typically occur through healthcare facilities that integrate Wondercel’s therapies into their treatment offerings, facilitating access for patients in need. The revenue model is designed to accommodate different client needs, thus allowing flexibility in how these therapies are accessed while ensuring consistent company growth through strategic collaborations and distribution agreements. Wondercel Therapeutics aims to develop revolutionary cell therapy products for cancer and other serious diseases by advancing technological breakthroughs in cell therapy and providing patients with more effective treatment options.
Who invested in Wondercel Therapeutics
3 investors across 2 rounds
See all investors in Wondercel Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Wondercel Therapeutics
Who invested in Wondercel Therapeutics?
Wondercel Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Wondercel Therapeutics raised?
Wondercel Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Wondercel Therapeutics last raise money?
Wondercel Therapeutics's most recent round on record is a Series A, in Jul 2026.
What does Wondercel Therapeutics do?
, trading as Wondercel Therapeutics, is a cell and gene therapy developer dedicated to exploring solutions to the shortcomings of existing cell drugs and developing safer and more economical next-generation immune cell therapy technologies to unleash the unlimited potential of human immune cells in the treatment of tumors, organ transplantation, and autoimmune diseases.
Where is Wondercel Therapeutics headquartered?
Wondercel Therapeutics is headquartered in Shenzhen, China.
Which VCs invest in companies like Wondercel Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Wondercel Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Wondercel Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.